Sinohealth Technology Holdings Limited (HKG:2361)
Hong Kong · Delayed Price · Currency is HKD 4.085
-0.105 (-2.51%)
Sep 30, 2026, 6:10 PM HKT
HKG:2361 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 432.68 | 419.09 | 403.73 | 396.19 | 356.67 | 324.17 | |
Revenue Growth | 10.34% | 3.81% | 1.90% | 11.08% | 10.03% | 60.42% |
Cost of Revenue | 175.4 | 170.04 | 170.53 | 172.72 | 197.56 | 131.53 |
Gross Profit | 257.28 | 249.05 | 233.2 | 223.47 | 159.11 | 192.64 |
Selling, General & Admin | 80.5 | 75.78 | 78.58 | 67.05 | 77.77 | 68.95 |
Research & Development | 79.29 | 73.57 | 64.77 | 61.09 | 60.41 | 53.71 |
Other Operating Expenses | - | - | - | - | - | 0.02 |
Operating Expenses | 173.24 | 157.43 | 152.69 | 145.75 | 140.86 | 125.19 |
Operating Income | 84.05 | 91.62 | 80.51 | 77.72 | 18.25 | 67.45 |
Interest Expense | -0.35 | -0.44 | -0.62 | -0.64 | -0.41 | -0.53 |
Interest & Investment Income | 20.78 | 23.5 | 26.88 | 27.17 | 15.11 | 6.97 |
Earnings From Equity Investments | -3 | -0.47 | - | - | - | -0.42 |
Currency Exchange Gain (Loss) | - | - | 4.86 | 2.29 | 9.53 | 0.04 |
Other Non Operating Income (Expenses) | -20.14 | -8.75 | 8.46 | 4.19 | 11.44 | 16.1 |
EBT Excluding Unusual Items | 81.33 | 105.47 | 120.09 | 110.73 | 53.92 | 89.61 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.04 | 4.82 |
Gain (Loss) on Sale of Assets | 0.06 | 0.06 | - | - | 0.52 | - |
Other Unusual Items | - | - | 0.06 | 0.01 | - | 1.11 |
Pretax Income | 81.39 | 105.53 | 120.15 | 110.74 | 54.47 | 95.53 |
Income Tax Expense | 8.01 | 11.03 | 8.33 | 9.8 | 0.26 | 23.55 |
Earnings From Continuing Operations | 73.38 | 94.5 | 111.82 | 100.94 | 54.21 | 71.98 |
Minority Interest in Earnings | -2.04 | -1.06 | -1.17 | 1.09 | 1.55 | 6.84 |
Net Income | 71.34 | 93.44 | 110.65 | 102.03 | 55.76 | 78.81 |
Net Income to Common | 71.34 | 93.44 | 110.65 | 102.03 | 55.76 | 78.81 |
Net Income Growth | -23.88% | -15.55% | 8.45% | 82.99% | -29.25% | 16.03% |
Shares Outstanding (Basic) | 378 | 452 | 410 | 426 | 411 | 373 |
Shares Outstanding (Diluted) | 378 | 452 | 410 | 426 | 411 | 373 |
Shares Change | -7.31% | 10.12% | -3.72% | 3.76% | 10.06% | - |
EPS (Basic) | 0.19 | 0.21 | 0.27 | 0.24 | 0.14 | 0.21 |
EPS (Diluted) | 0.19 | 0.21 | 0.27 | 0.24 | 0.14 | 0.21 |
EPS Growth | -17.87% | -23.31% | 12.64% | 76.35% | -35.72% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 57.21 | 67.09 | 89.43 | 75.94 | 29.78 | 58.14 |
Free Cash Flow Per Share | 0.15 | 0.15 | 0.22 | 0.18 | 0.07 | 0.16 |
Dividend Per Share | 0.064 | 0.064 | 0.113 | 0.066 | 0.035 | - |
Dividend Growth | -43.26% | -43.26% | 71.35% | 86.93% | - | - |
Gross Margin | 59.46% | 59.43% | 57.76% | 56.41% | 44.61% | 59.43% |
Operating Margin | 19.42% | 21.86% | 19.94% | 19.62% | 5.12% | 20.81% |
Profit Margin | 16.49% | 22.30% | 27.41% | 25.75% | 15.63% | 24.31% |
Free Cash Flow Margin | 13.22% | 16.01% | 22.15% | 19.17% | 8.35% | 17.94% |
EBITDA | 87.21 | 94.91 | 83.15 | 80.15 | 20.91 | 69.53 |
EBITDA Margin | 20.16% | 22.65% | 20.59% | 20.23% | 5.86% | 21.45% |
D&A For EBITDA | 3.16 | 3.29 | 2.64 | 2.43 | 2.66 | 2.08 |
EBIT | 84.05 | 91.62 | 80.51 | 77.72 | 18.25 | 67.45 |
EBIT Margin | 19.42% | 21.86% | 19.94% | 19.62% | 5.12% | 20.81% |
Effective Tax Rate | 9.84% | 10.45% | 6.93% | 8.85% | 0.48% | 24.65% |